To the Point
To the Point

01.09.24

Treating OSD in 2024

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals). They also share some practice pearls and professional goals for the year ahead.

View full description +

MORE EPISODES

08.13.25

Building Out a Dry Eye and Aesthetics Practice

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Shane Swatts, OD

07.08.25

Takeways From the TFOS DEWS III Report

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO; and Vin T. Dang, OD, FAAO

06.11.25

A Lesson in Blink Mechanics and Dry Eye

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Cory J. Lappin, OD, MS, FAAO

05.12.25

Is it Dry Eye or Corneal Pathology?

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Bita Asghari, OD, FAAO, FSLS

04.09.25

Take Ownership of Your Career in Dry Eye

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO

03.11.25

Learn How Vitamin A Supports the Ocular Surface

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Kaleb Abbott, OD, FAAO

02.10.25

Beware the Dry Eye Masqueraders

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Mile Brujic, OD, FAAO

01.02.25

OSD’s Greatest Hits: 2024 Edition

Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO

Show More